Suncrete, Inc. 8-K

What Happened
Suncrete, Inc. filed a Form 8‑K (Items 3.02 and 5.02) reporting that on April 20, 2026 the Board expanded from seven to nine directors and appointed Charles E. Owens (Class I, term to 2027 Annual Meeting) and Noreen E. Skelly (Class II, term to 2028 Annual Meeting). Both were named to the Board’s Audit Committee (Skelly will serve as Audit Committee Chair) and were determined by the Board to be “independent” under SEC and Nasdaq rules.

Key Details

• Board change: size increased from 7 to 9 directors; appointments effective April 20, 2026 (Owens — Class I; Skelly — Class II).
• Audit Committee: members now Bretton Johnston, Charles Owens and Noreen Skelly; Skelly named Chair.
• Director equity awards (unregistered): the Board granted restricted stock under the Suncrete 2026 Omnibus Incentive Plan totaling 528,000 shares across eight directors (see allocations below). Grants were issued under Section 4(a)(2) and/or Regulation D exemptions.
  • Ned N. Fleming, III (Class B): 144,000 shares
  • Mark R. Matteson (Class B): 96,000 shares
  • Andrew R. Heyer (Class A): 48,000 shares
  • William Holden (Class A): 48,000 shares
  • Bretton Johnston (Class B): 48,000 shares
  • Charles Owens (Class B): 48,000 shares
  • David Rees‑Jones (Class B): 48,000 shares
  • Noreen Skelly (Class B): 48,000 shares
• Vesting: restricted shares vest two‑thirds on the second anniversary of the grant and one‑third on the third anniversary, subject to continued service.

Why It Matters
For investors, the filing signals governance changes (two new independent directors and a new Audit Committee chair) that could affect oversight and financial reporting. The director compensation in restricted stock represents equity-based, potentially dilutive compensation (issued as unregistered securities) that vests over two to three years, aligning directors’ interests with shareholders but increasing outstanding share count if and when vested.